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Abstract
Background: Increasing physical activity is a cornerstone in the treatment of type 2 diabetes and in general
practice it is a challenge to achieve long-term adherence to this life style change. The aim of this study was to
investigate in a non-randomised design whether the introduction of motivational interviewing combined with
fitness tests in the type 2 diabetes care programme was followed by a change in cardio-respiratory fitness
expressed by VO2max, muscle strength of upper and lower extremities, haemoglobin A1c (HbA1c) and
HDL-cholesterol.
Methods: Uncontrolled 18-month intervention study with follow-up and effect assessment every 3 months in a
primary care unit in Denmark with six general practitioners (GPs). Of 354 eligible patients with type 2 diabetes, 127
(35.9%) were included. Maximum work capacity was tested on a cycle ergometer and converted to VO2max. Muscle
strength was measured with an arm curl test and a chair stand test. The results were used in a subsequent
motivational interview conducted by one of the GPs. Patients were encouraged to engage in lifestyle exercise and
simple home-based self-managed exercise programmes. Data were analysed with mixed models.
Results: At end of study, 102 (80.3%) participants remained in the intervention. Over 18 months, VO2max increased
2.5% (p = 0.032) while increases of 33.2% (p < 0.001) and 34.1% (p < 0.001) were registered for the arm curl test
and chair stand test, respectively. HDL-cholesterol increased 8.6% (p < 0.001), but HbA1c remained unchanged (p =
0.57) on a low level (6.8%). Patients without cardiovascular disease or pain from function limitation increased their
VO2max by 5.2% (p < 0.0001) and 7.9% (p = 0.0008), respectively.
Conclusions: In this 18-month study, participants who had repeated fitness consultations, including physical
testing and motivational interviewing to improve physical activity, improved VO2max, muscle strength, and lipid
profile. Our results indicate that physical testing combined with motivational interviewing is feasible in a primary
health care setting. Here, a fitness consultation tailored to the individual patient, his/her comorbidities and
conditions in the local area can be incorporated into the diabetes programme to improve patients’ muscle
strength and cardio-respiratory fitness.
Background
Increases in cardio-respiratory fitness, muscle strength and
level of physical activity are associated with decreased
mortality and protect against age-related disabilities [1-7].
A substantial proportion of patients with type 2 diabetes
have low levels of physical fitness and do not engage in
the recommended level of physical activity [1,8]. These
patients have increased cardiovascular mortality [9] and
many comorbidities [10], e. g. hypertension, cardiovascular
disease and arthritis, which may preclude some physical
activities or require evaluation by a physician before the
activities can be undertaken.
Regular exercise in type 2 diabetic individuals may have
a significant effect on VO2max and may result in
decreased HbA1c [11,12]. Similarly, HDL-cholesterol
increases with cardio-respiratory fitness [13,14]. It has
also been demonstrated that progressive resistance * Correspondence: Lohmann@dadlnet.dk
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patients [15].
Interventions that include fitness testing and individual
exercise prescription are associated with more effect on
fitness outcomes than interventions without these ele-
ments [16], and in recent years the use of individual
behavioural approaches to increase physical activity has
been advocated. It seems relevant to use motivational
interviewing and include testing of muscle strength, car-
dio-respiratory fitness as well as exercise prescription in
the motivational armamentarium of a diabetes care pro-
gramme [17-22]. In a study of home-based resistance
training in elderly people it was concluded that a positive
attitude towards exercise and a sense of control over it
were associated with adherence to the exercise regimen
[23]. There are many laboratory studies with supervised
exercise that demonstrate an effect on cardiovascular
fitness and muscle strength, but results from general
practice are scarce [11].
The over-all purpose of the present study was to see
whether it was feasible for general practitioners (GPs)
and their staff to motivate people with type 2 diabetes to
increase and maintain their muscle strength and cardio-
respiratory fitness by self-managed physical activities
during an 18-month intervention period. We assumed
that by providing patients with knowledge of their own
muscle strength and cardio-respiratory fitness, they
would become aware of discrepancies between their cur-
rent physical fitness and personal goals for future health,
and this realisation could induce behavioural changes
[16,20]. In those patients who accepted to undergo the
intervention, we measured a number of outcomes before,
during and after the inclusion of fitness tests and motiva-
tional interviewing in the patients’ regular diabetes con-
trol consultations. The primary outcomes were VO2max
(maximal oxygen uptake, ml O2 kg
-1 min
-1), muscle
strength of upper and lower extremities, haemoglobin
A1c (HbA1c), and HDL-cholesterol during the 18-month
intervention period. Secondary outcomes were waist cir-
cumference, body mass index (BMI), systolic and diasto-
lic blood pressure, fasting plasma glucose, total
cholesterol, LDL-cholesterol, and triglycerides.
Methods
Study design and participants
The study was designed as an uncontrolled study in a pri-
mary health care unit with six GPs providing health ser-
vices to approx. half of the 20,000 population of a town
in Denmark. All health care providers in the unit partici-
pated. In Denmark, routine care of patients with type 2
diabetes is usually given by GPs and practice nurses in
primary care units in a national structured diabetes pro-
gramme recommending control every 3 months.
Of 399 patients with known type 2 diabetes, 127 were
included (Figure 1). All were Caucasians. During the
study, participants were considered lost to follow-up
after non-response to one reminder. The reasons for
exclusion or loss to follow-up appear from Figure 1.
The ethics committee of West Zealand approved the
protocol. Patients gave written informed consent.
The fitness consultation
The six GPs involved were trained in the principles of
aerobic and resistance exercise testing and training in a
3-hour session, and they were introduced to the strate-
gies and techniques of motivational interviewing in
another 3-hour session conducted by a researcher with
wide experience of motivational interviewing.
During the 18 months of intervention, the patients
were seen on two different days every three months in
connection with the scheduled visits in the usual dia-
betes care programme.
On the first day, the practice nurse or the laboratory
technician tested maximum work capacity (Wattmax)
and muscle strength and measured weight, height, waist
circumference, blood pressure and HbA1c. At baseline
and after 9 and 18 months, fasting plasma glucose, total
cholesterol, HDL-cholesterol, fasting triglycerides, serum
creatinine, HbA1c, and urinary albumin/creatinine-ratio
were measured as well.
On the second day, the GPs, in conjunction with the
usual diabetes control, carried out a fitness consultation.
At every fitness consultation the GPs had to judge and
note in the patient file the patient’sp o s i t i o ni nr e l a t i o n
to the Stages of change model (Pre-contemplation, Con-
templation, Preparation, Action, Maintenance and
Relapse). The consultation was then held bearing this
knowledge in mind. The doctors and patients worked
with ambivalent attitudes, using the results of the physi-
cal tests, the pro and cons of increased physical activity,
resistance, readiness and ability to change. The GPs
were recommended not to try to persuade patients to
certain behaviour changes but to accept the choices
made by the patients.
Results of the physical tests were presented to the
patient using age- and sex-stratified nomograms and
information about changes since the previous visit
[2,24]. Life-style exercise, i.e. increasing physical activity
in daily life, actions such as walking up and down stairs
instead of using the lift, cycling instead of using the car,
gardening etc., were suggested. A realistic goal of physi-
cal activity was negotiated, aiming at 2,500 kcal per
week corresponding to approximately a half-hour walk-
ing and a half-hour cycling a day seven days a week.
This is a level where the maximal effect on cardiovascu-
lar risk and HbA1c might be expected [4,25,26].
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Page 2 of 10Self-managed resistance exercise was suggested for
each of the major muscle groups three times a week gra-
dually progressing to two or three sets with a resistance
that could be done between a minimum of 10 times and
a maximum of 15 times [24].
Tests of fitness and muscle strength
Before testing, all patients had a 6-minute light warm-up
period on the bicycle ergometer with 50% of maximum
workload. Tests of muscle strength were done as described
in “Senior Fitness Test” [2] by two tests: (a) an arm curl
test during which the patient lifted weights from full
extension to maximum flexion as many times as possible
within 30 seconds. The outcome was the number of flex-
ions; (b) a chair stand test where the patient stood up and
sat down from a 40 cm high chair as many times as possi-
ble within 30 seconds. The outcome was the number of
stand ups. The chair stand test is a measure of lower body
strength and has a moderately high correlation to leg
press scores (R = 0.78 for men and R = 0.71 for women).
Figure 1 Flow of patients through the trial and the number of different physical tests done at fitness consultation No. 1, 4 and 7.
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Page 3 of 10The arm curl test is a measure of upper body strength and
has a moderately high correlation to combined 1-RM
(repetition max) biceps, chest, and upper back (R = 0.84
for men and R = 0.79 for women). The test-retest reliabil-
ity (95% confidence interval) for the chair stand test is 0.89
(0.79-0.93) and for the arm curl test 0.81 (0.72-0.88) [2].
Cardio-respiratory fitness was tested with an individua-
lized symptom-limited ramp cycle ergometer (Monark®)
test where we used a protocol with an individualized
initial workload and a 12.5-watt increase per min. aiming
at a testing time between six and 10 minutes. The results,
i.e. the Wattmax attained, were converted to VO2max (ml
O2 kg
-1 min
-1) by use of conversion formulas [27]. This
method of measuring cardio-respiratory fitness has a
high correlation, R = 0.97, with measurements of pul-
monary ventilation and gas exchange [27].
We did not screen all participants with stress testing
before exercise testing, but all were assessed clinically
and with a resting ECG with regard to the risk of
ischaemic heart disease and, at the discretion of the GP,
referred to a cardiologist before testing [28]. Contraindi-
cations for the maximal exercise test were blood pres-
sure > 180/110 mmHg, unstable angina pectoris, severe
ischaemia on resting ECG, severe heart arrhythmia,
aorta stenosis, pacemaker with fixed heart rate, auto-
nomic neuropathy (resting heart rate > 100 bpm, ortho-
static vertigo), proliferative retinopathy, and acute
disease [24,28]. Patients on insulin treatment with blood
glucose < 7 mmol/l were given 20 g glucose 15 minutes
before testing. All tests were stopped if the patient felt
unwell in any way. The health centre had access to
resuscitation equipment including a heart starter.
Biochemical and clinical variables
All blood samples were taken in the morning after an
eight-hour overnight fast and a resting period of at least
15 min and no hard physical activity within the fore-
going two hours. Samples were analysed at Slagelse
Hospital. Fraction of HbA1c was measured by a high
performance liquid chromatography method (a Tosoh
Automated Glycohaemoglobin Analyzer HLC-723 G.
Reference interval: 0.042-0.063). Serum total cholesterol
concentration was measured enzymatically with choles-
terol esterase-cholesterol oxidase-peroxidase reagent.
Serum triglyceride concentrations were determined
enzymatically with a lipase-glycerolkinase-glycerol-3-
phosphate oxidase-peroxidase reagent. HDL-cholesterol
was determined by a homogeneous enzymatic colori-
metric method. Plasma glucose was measured by a hex-
okinase method. In freshly voided morning urine,
creatinine was determined by a Jaffé reaction and albu-
min by an immunoturbidimetric method.
Body weight and height were measured without shoes
and outer garments on the same scales throughout the
study. BMI was calculated as (weight in kg)/(height in
metres)
2. Waist circumference was measured to the
nearest cm in the mid-horizontal plane between lowest
rib and iliac crest. Blood pressure was measured after
10 min. rest in the seated position as the lowest of three
values using a mercury sphygmomanometer.
Pain with function limitation was defined as pain from
joints and/or muscles in arms, shoulders, legs and/or back
which reduced the performance at the physical tests at the
9- and/or 18-month follow-up as indicated by the patient.
Cardiovascular disease (CVD) was defined as history of
myocardial infarction and/or verified stenosis of coronary
arteries and/or stroke and/or arteriosclerosis of the lower
extremities verified by distal pressure measurement
recorded at baseline and/or after 9 and/or 18 months.
Statistical analysis
Differences between study subjects and excluded patients
were investigated by c
2 tests or Kruskal-Wallis tests. The
development of each outcome variable was described in a
mixed model with a separate fixed effect for each exami-
nation, and a random patient intercept [29]. The concate-
nation of fixed effects was interpreted as the average
development of the outcome, and was superimposed on
the cross-sectional distributions of the outcome (shown
as box-plots) in Figure 2. Whether the outcome remains
the same over time was tested by a Wald test for the null
hypothesis that all parameters of the fixed effects were
the same. A heuristic measure of increase was Δ:t h e
difference between the modelled baseline outcome and
the modelled outcome at the seventh examination.
A power calculation shows that the study has a power
of 80% to detect a difference in change in VO2max from 0
(no change) to 1.3 ml O2 kg
-1 min
-1 during 18 months
when n = 127.
Subgroup analyses were done by adding the stratifica-
tion variable to the mixed model both as a main fixed
effect and interacting with the fixed effects of the sepa-
rate examinations. This allowed for completely different
developments in the subgroups. The test for the signifi-
cance of the difference between the developments was
the Wald test for the null hypothesis that all parameters
of fixed effects containing the subgroup variable were
zero. Here Δ was the difference between the subgroup-
specific modelled baseline and seventh examination out-
come. Significance of the comparison tests was deter-
mined controlling for the false discovery rate at 5% [30].
Data were analysed with SAS PROC MIXED.
Results
Of 354 eligible patients, 127 (35.9%) participated in the
study. There was no statistically significant difference
between the 227 non-responders and the 127 partici-
pants with regard to age (67.5/67.0 years, p = 0.77),
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Page 4 of 10gender (women, 42.3/42.5%, p = 0.96) and HbA1c
(6.8/6.9%, p = 0.30) before the start of intervention
(Figure 1). At baseline, participants were characterised
by a low HbA1c and a high comorbidity (Table 1). Thir-
teen patients had atypical courses due to severe disease
(myocardial infarction, stroke, accidents, and cancer)
and one patient started participation in a placebo trial
after inclusion. Test results from these patients were
excluded from analysis from the date of the event.
Primary outcome measures
Over the 18 months, clear average increases of approxi-
mately one third were obtained for both arm curl test
and chair stand test, while VO2max increased moderately
(Table 2). The average increase in muscle strength aba-
ted over the 18 months but never declined (Figure 2).
HDL-cholesterol also increased, but HbA1c remained
unchanged on a low level.
Subgroup analyses
The development of VO2max varied with age, sex, CVD
and pain with function limitation (Table 2). In a full
Figure 2 C h a n g e so v e r1 8m o n t h si na r mc u r lt e s t( A ) ,c h a i r
stand test (B), and VO2max (C).
Table 1 Baseline characteristics of the patients
Characteristic
Sex (men/women) 73 (57%)/54 (43%)
Age (years) 67.0 (59.8-73.8)
Diabetes duration (years) 3 (2-8)
School education (basic/further) 39 (31%)/88 (69%)
Marital status (single/cohabiting) 29 (23%)/98 (77%)
VO2max (ml kg
-1 min
-1) 19.0 (17.0-22.5)
Arm curl test (times per 30 sec) 17 (14-19)
Chair stand test (times per 30 sec) 14 (12-17)
Haemoglobin A1c (%) 6.8 (6.4-7.5)
HDL-cholesterol (mmol/l) 1.3 (1.1-1.5)
Total cholesterol (mmol/l) 5.0 (4.2-5.6)
LDL-cholesterol (mmol/l) 2.7 (2.2-3.3)
Fasting triglycerides (mmol/l) 1.5 (1.1-2.3)
Waist circumference (cm, men) 105 (101-115)
Waist circumference (cm, women) 99 (92-107)
Body mass index (kg/m
2) 29.6 (26.3-33.3)
Systolic pressure (mmHg) 140 (130-150)
Diastolic pressure (mmHg) 80 (75-85)
Fasting plasma glucose (mmol/l) 7.7 (6.8-9.1)
Antihypertensive medication (N/Y) 36 (28%)/91 (72%)
Antidiabetic treatment (diet/oral agents/
insulin)
37 (29%)/70 (55%)/20
(16%)
Statin treatment (N/Y) 49 (39%)/78 (61%)
Smoking (N/Y) 99 (78%)/28 (22%)
Albumin/creatinine ratio (≤3.5/>3.5) 97 (76%)/30 (24%)
Cardiovascular disease
a (N/Y) 61 (48%)/66 (52%)
Pain with function limitation
b (N/Y) 53 (42%)/74 (58%)
bRecorded after 9 and/or 18 months.
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Page 5 of 10Table 2 Developments in primary outcome measures during the study according to baseline variables
VO2max
(ml/kg/min)
Arm curl test
(times per 30 sec)
Chair stand test
(times per 30 sec)
Haemoglobin A1c
(%)
HDL-cholesterol
(mmol/l)
n Δ SE % p
a Δ SE % p
a Δ SE % p
a Δ SE % p
a Δ SE % p
a
Total 127 0.46 0.20 2.5 0.032 5.9 0.30 33.2 <0.0001 5.1 0.31 34.1 <0.0001 0.020 0.066 0.3 0.57 0.11 0.02 8.6 <0.0001
Sex Male 73 0.58 0.26 2.9 * 6.3 0.40 34.2 5.6 0.40 36.4 -0.069 0.088 -1.0 0.09 0.03 7.0
Female 54 0.34 0.31 2.0 5.3 0.46 31.8 4.4 0.47 31.0 0.129 0.098 1.8 0.14 0.03 10.2
Age ≤67 years 63 0.58 0.26 2.7 * 7.0 0.42 37.9 * 6.0 0.41 37.9 * 0.042 0.092 0.6 0.10 0.03 8.1
>67 years 64 0.32 0.31 2.0 4.7 0.43 27.8 4.1 0.45 29.2 -0.002 0.096 -0.0 0.13 0.03 9.3
Diabetes duration ≤1 year 31 0.16 0.37 0.8 7.0 0.60 38.4 6.8 0.58 45.2 * -0.066 0.130 -1.0 0.14 0.04 10.0
>1 year 96 0.58 0.23 3.2 5.5 0.35 31.2 4.5 0.36 30.0 0.049 0.077 0.7 0.11 0.03 8.1
School education Further 88 0.56 0.23 2.9 6.1 0.36 33.3 4.9 0.36 31.4 0.079 0.078 1.1 0.08 0.03 6.2
Basic 39 0.21 0.38 1.2 5.3 0.57 32.6 5.7 0.58 42.0 -0.128 0.123 -1.8 0.19 0.04 14.8
Marital status Single 29 -0.37 0.49 -2.3 3.9 0.68 23.0 3.4 0.71 24.2 * 0.168 0.153 2.3 0.14 0.05 10.7
Co-habiting 98 0.62 0.22 3.2 6.4 0.34 35.4 5.5 0.34 36.4 -0.013 0.073 -0.2 0.11 0.02 8.2
BMI <29.62 kg/m
2 64 0.48 0.28 2.5 5.9 0.43 31.9 5.6 0.43 36.7 0.009 0.094 0.1 0.14 0.03 10.2 *
≥29.62 kg/m
2 63 0.44 0.29 2.4 5.9 0.43 34.7 4.5 0.44 31.2 0.030 0.093 0.4 0.09 0.03 6.9
Waist circum-ference <♂/♀ median 60 0.84 0.27 4.3 5.9 0.44 32.0 5.6 0.43 36.6 -0.001 0.096 -0.0 0.10 0.03 7.4
≥♂/♀ median 67 0.04 0.29 0.2 5.9 0.43 34.3 4.6 0.44 31.4 0.039 0.092 0.5 0.12 0.03 9.8
Systolic pressure ≤130 mmHg 50 0.48 0.32 2.6 5.6 0.50 31.2 3.9 0.50 25.9 0.137 0.109 1.9 0.11 0.04 8.5
>130 mmHg 75 0.51 0.26 2.7 6.3 0.39 35.5 6.0 0.40 40.0 -0.050 0.086 -0.7 0.12 0.03 8.8
Diastolic pressure ≤80 mmHg 89 0.27 0.25 1.5 5.9 0.37 32.9 5.0 0.38 33.4 0.063 0.081 0.9 0.12 0.03 9.0
>80 mmHg 36 0.93 0.35 4.9 6.2 0.54 36.3 5.6 0.55 36.9 -0.070 0.121 -1.0 0.10 0.04 8.2
Antihypertensive
medi-cation
No 36 1.07 0.35 5.4 7.3 0.57 40.6 6.1 0.58 40.1 0.128 0.127 1.9 0.16 0.04 12.1
Yes 91 0.17 0.24 0.9 5.3 0.36 30.2 4.7 0.36 31.7 -0.019 0.077 -0.3 0.10 0.03 7.3
Albumin/
creatinine ratio
≤3.5 97 0.58 0.22 3.1 6.7 0.34 38.1 * 5.8 0.35 39.1 * 0.033 0.075 0.5 * 0.12 0.02 8.7
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0Table 2: Developments in primary outcome measures during the study according to baseline variables (Continued)
>3.5 30 -0.05 0.45 -0.3 3.4 0.60 18.5 2.9 0.61 19.5 -0.036 0.134 -0.5 0.10 0.04 8.2
Fasting plasma
glucose
≤7 mmol/l 38 0.21 0.36 1.1 6.6 0.54 37.0 6.1 0.55 42.3 0.064 0.119 1.0 * 0.11 0.04 7.9
>7 mmol/l 89 0.58 0.24 3.2 5.6 0.37 31.5 4.6 0.37 30.5 -0.005 0.079 -0.1 0.11 0.03 8.9
Diabetes
treatment
Diet alone 37 0.42 0.36 2.2 7.0 0.57 38.8 6.7 0.55 44.8 * 0.128 0.126 2.0 0.16 0.04 11.3
Oral agents 70 0.73 0.27 3.9 5.9 0.40 33.7 5.0 0.41 32.9 -0.016 0.089 -0.2 0.11 0.03 8.5
Insulin 20 -0.31 0.54 -1.7 3.9 0.75 21.8 2.4 0.78 16.9 -0.041 0.159 -0.6 0.06 0.05 4.5
Statin treatment
b None 38 1.36 0.36 7.5 6.3 0.56 36.1 5.3 0.57 37.8 0.192 0.120 2.7 0.18 0.04 13.3
Un-changed 78 0.16 0.26 0.9 5.9 0.39 33.0 5.0 0.40 33.0 -0.061 0.086 -0.9 0.08 0.03 5.8
Initiated 11 -0.33 0.62 -1.7 4.8 0.92 26.5 5.0 0.91 31.2 -0.043 0.204 -0.6 0.13 0.07 9.7
Smoking No 99 0.45 0.21 2.3 5.9 0.33 33.2 5.2 0.34 33.9 0.115 0.072 1.6 * 0.09 0.02 6.7
Yes 28 0.55 0.54 3.1 5.6 0.72 32.6 4.9 0.77 35.0 -0.454 0.157 -6.3 0.24 0.05 18.5
Pain with function
limitation
No 53 1.53 0.32 7.9 * 6.0 0.49 32.4 5.7 0.48 37.7 -0.006 0.108 -0.1 0.17 0.03 12.2
Yes 74 -0.15 0.25 -0.8 5.9 0.39 34.1 4.7 0.40 32.0 0.036 0.084 0.5 0.08 0.03 6.5
Cardiovascular
disease
No 66 1.03 0.23 5.2 * 6.0 0.39 33.3 5.5 0.38 35.2 0.012 0.084 0.2 0.12 0.02 8.9
Yes 45 -0.77 0.37 -4.3 5.7 0.54 32.6 4.1 0.55 29.4 -0.082 0.118 -1.1 0.05 0.03 3.8
n is number of patients. Δ is a measure of absolute increase defined as the difference between the (subgroup-specific) modelled baseline and the 18-month examination outcome. The corresponding increase,
relative to the modelled baseline examination outcome, is indicated under %.
a Differences between subgroups are assessed by a Wald test for the time-subgroup interaction. To account for multiple testing, the
tests that remained significant after controlling for the false discovery rate at 5% are indicated with a *.
b Indicates whether patients had unchanged statin treatment during the study or stated statin treatment
during the study.
L
o
h
m
a
n
n
e
t
a
l
.
B
M
C
F
a
m
i
l
y
P
r
a
c
t
i
c
e
2
0
1
0
,
1
1
:
8
3
h
t
t
p
:
/
/
w
w
w
.
b
i
o
m
e
d
c
e
n
t
r
a
l
.
c
o
m
/
1
4
7
1
-
2
2
9
6
/
1
1
/
8
3
P
a
g
e
7
o
f
1
0multivariate model including all the baseline variables
listed in Table 2 as predictors and VO2max as outcome,
only CVD (p = 0.001) and pain with function limitation
(p = 0.023) were statistically significant. Patients without
cardiovascular disease or pain from function limitation
increased their VO2max by 5.2% (p < 0.0001) and 7.9%
(p = 0.0008), respectively. All subgroups increased their
muscle strength, but high age and microalbuminuria
were associated with relatively small improvements in
muscle strength tests.
Secondary outcome measures
Waist circumference, BMI and fasting plasma glucose did
not change, and there was a slight increase in systolic and
diastolic pressure. The lipid profile improved (Table 3).
The course of the intervention
Ten of the 127 participants were referred to initial super-
vision by a physiotherapist, and two attended local fitness
centres, but most chose lifestyle exercise or self-managed
home-based exercise programmes or both. The pro-
grammes included aerobic training using an exercise bike
and resistance training with weights or use of own body
weight [2]. The intervention was safe and well tolerated
with a dropout rate of 19.6% despite a high degree of
comorbidity (Table 1). One maximal exercise test was
stopped because the patient felt unwell, but there were
no other complications associated with the test proce-
dures except for slight tenderness of joints and muscles.
Reasons for not performing all three tests at the final ses-
sion were musculoskeletal disease (14/102), blood pres-
sure >180/110 (7/102), heart disease (9/102), and acute
illness (1/102). The extra time attributed to the expan-
sion of the usual diabetes control to include a fitness con-
sultation was estimated to be 10 min.
Discussion
In this 18-month uncontrolled intervention study,
repeated fitness consultations including fitness testing
and motivational interviewing resulted in the partici-
pants having increased muscle strength and VO2max,
and an improved lipid profile, while HbA1c remained
unchanged on a low level. Among the secondary out-
come measures, waist circumference, BMI and fasting
plasma glucose were unchanged, blood pressures
increased slightly, whereas total cholesterol and LDL-
cholesterol decreased.
Comparison with relevant literature
In the studies by David et al. [31,32], six months of
supervised progressive high-intensity resistance training
three times a week in older (mean age 67.6 years) type 2
diabetic patients with few comorbidities resulted in a
41.7% increase in upper body muscle strength and a
28.0% increase in lower body muscle strength. Addi-
tional home-based resistance training for 6 months was
effective in maintaining the gymnasium-based improve-
ments in muscle strength. These results are comparable
with the increase and maintenance of muscle strength
attained in the present study considering its less inten-
sive intervention (Table 2 and Figure 2).
A meta-analysis has reported an 11.8% increase of
VO2max in structured aerobic exercise studies with the fol-
lowing average characteristics: 3.4 sessions per week,
49 min. per session for 20 weeks with exercise intensities
of 50-75% of VO2max [11]. The study populations in the
meta-analysis were selected so they had a minimum of
cardiovascular or orthopaedic limitations and were on
average 12 years younger than the present study popula-
tion. During our intervention, there was a slight (2.4%) but
significant increase in VO2max for the whole group. There
was a more substantial increase of 7,9% in the subgroup
(n = 53) without function-limiting pain and 5,2% in the
subgroup (n = 61) without CVD (Table 2). In light of
these post hoc explanatory subgroup analyses, our study
indicated that physical tests and motivational interviewing
had an impact comparable with supervised exercise ses-
sions on muscle strength and VO2max.
There is a steep inverse relationship between cardio-
respiratory fitness and mortality in men with documented
diabetes [5]. This could mean that an improvement in fit-
ness, like the one we observed, is of clinical significance.
In an observational prospective study of men, an increase
of 7.0 ml/kg/min in VO2max over 4.9 years was associated
with an estimated reduction of 30% in mortality risk dur-
ing the following 5.1 years [7]. HbA1c did not change in
participants during the present study, which perhaps is
explained by the low baseline level of HbA1c [33]. The
increase in HDL-cholesterol may be a result of increased
muscle strength and increased VO2max [34]. The interven-
tion had no impact on BMI and waist circumference.
Nevertheless the intervention may have had a clinically
significant effect on health as the inverse gradient
Table 3 Changes in secondary outcome measures during
the study period
Secondary outcome measure Δ SE p
Waist circumference (cm) 0.28 0.54 0.93
BMI (kg/m
2) 0.13 0.09 0.13
Systolic blood pressure (mmHg) 2.50 1.83 0.037
Diastolic blood pressure (mmHg) 1.38 0.92 0.0009
Fasting plasma glucose (mmol/l) 0.12 0.19 0.79
Total cholesterol (mmol/l) -0.25 0.08 0.006
LDL-cholesterol (mmol/l) -0.31 0.07 <0.0001
Triglycerides (mmol/l) -0.09 0.14 0.66
Δ is defined as the difference between the modelled baseline and the 18-
month examination outcome. SE, standard error. n = 127. For baseline values
see Table 1.
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diabetes mentioned above is independent of BMI [4,5].
The improvement in glycaemic control following endur-
ance and strength training may also be observed with
unchanged BMI [35].
Strengths and limitations of the study
The study was done in the setting of a primary health
care unit using primary care practitioners to carry out
the intervention. The whole town was aware of the pro-
ject, which made it difficult and demanding to do a ran-
domised controlled trial, e.g. using the idea of waiting list
controls. Unlike most other studies, patients with cardio-
vascular or musculoskeletald i s e a s ew e r en o te x c l u d e d
[11]. The idea of physical testing was completely new to
the patients and this, in combination with the relatively
high median age, was probably the major reason for the
low participation rate.
The lack of a control group is a major limitation of the
study which leaves the possibility that the improvements
in outcomes could be due to the general development in
the natural history of type 2 diabetes and, for the physical
tests in particular, to some degree of habituation. How-
ever, it is unlikely that the observed improvements in car-
dio-respiratory fitness and muscle strength can be
explained entirely by these effects. Firstly, control groups
in previous randomised studies show a decrease in
VO2max of 1% over a period of 20 weeks and small non-
significant increases of 1.5% and 5% in upper and lower
body strength [11,31]. Secondly, the expected age-related
decline in muscle strength and VO2max over 18 months
can be estimated to be 2.5% and 2.2% respectively in the
population of the present study [2,36]. Thirdly, if habitua-
tion explained the improvement, the same development
should be expected in the different subgroups, and this is
not the case (Table 2).
The arm curl test and the chair stand test are vali-
dated methods for measuring muscle strength in upper
and lower extremities. These tests have a high test-retest
reliability, are simple to use in everyday practice, and
can be done by nearly all patients [2] (Figure 1). Until
now, experience with these tests has been limited to a
population over 60 years of age. In this study, it was
assumed that they could also be used with younger peo-
ple to measure changes in muscle strength. The bicycle
ergometer test is known to give an accurate estimate of
VO2max [24,27], but about one third of the type 2 dia-
betic participants were unable to do the test because of
contraindications and comorbidity (Figure 1). However,
all the participants were able to perform at least one of
the three tests so all got a result that could be used in
the motivational interview.
Conclusion
Clinical implementation of increased physical activity in
the treatment of type 2 diabetes is still far from being
standard practice. Our results indicate that physical test-
ing combined with motivational interviewing can be
done in a primary health care setting. Here, a fitness
consultation tailored to the individual patient, his/her
comorbidities and conditions in the local area can be
incorporated into the diabetes programme to improve
patients’ muscle strength and cardio-respiratory fitness.
The extra workload caused by fitness consultations in
primary care could for instance be carried by practice
nurses or physiotherapists who have received training in
motivational interviewing and physical testing. Rando-
mised trials are needed to confirm our findings and to
optimise recommendations for the content and the fre-
quency of the fitness consultations [37].
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